This document is an excerpt from the EUR-Lex website
Document 22024D0661
Decision of the EEA Joint Committee No 340/2021 of 10 December 2021 amending Annex II (Technical Regulations, Standards, Testing and Certification) to the EEA Agreement [2024/661]
Decision of the EEA Joint Committee No 340/2021 of 10 December 2021 amending Annex II (Technical Regulations, Standards, Testing and Certification) to the EEA Agreement [2024/661]
Decision of the EEA Joint Committee No 340/2021 of 10 December 2021 amending Annex II (Technical Regulations, Standards, Testing and Certification) to the EEA Agreement [2024/661]
OJ L, 2024/661, 14.3.2024, ELI: http://data.europa.eu/eli/dec/2024/661/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
|
Official Journal |
EN Series L |
|
2024/661 |
14.3.2024 |
DECISION OF THE EEA JOINT COMMITTEE No 340/2021
of 10 December 2021
amending Annex II (Technical Regulations, Standards, Testing and Certification) to the EEA Agreement [2024/661]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Regulation (EU) 2021/383 of 3 March 2021 amending Annex III to Regulation (EC) No 1107/2009 of the European Parliament and of the Council listing co-formulants which are not accepted for inclusion in plant protection products (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Regulation (EU) 2021/556 of 31 March 2021 amending Implementing Regulations (EU) 2017/1529 and (EU) No 540/2011 as regards the conditions of approval of the basic substance sodium chloride (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
|
1. |
The following indent is added in point 13 (Regulation (EC) No 1107/2009 of the European Parliament and of the Council):
|
|
2. |
The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
|
3. |
The following is added in point 13zzzzzzzzc (Commission Implementing Regulation (EU) 2017/1529): ‘, as amended by:
|
Article 2
The texts of Regulation (EU) 2021/383, Implementing Regulations (EU) 2020/2007 and (EU) 2021/556 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 11 December 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 10 December 2021.
For the EEA Joint Committee
The President
Rolf Einar FIFE
(2) OJ L 414, 9.12.2020, p. 10.
(3) OJ L 115, 6.4.2021, p. 26.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/661/oj
ISSN 1977-0677 (electronic edition)